Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IndexRUT P/E- EPS (ttm)-0.14 Insider Own45.00% Shs Outstand41.52M Perf Week-6.00%
Market Cap1.51B Forward P/E42.67 EPS next Y0.49 Insider Trans-1.50% Shs Float39.71M Perf Month-4.77%
Income-9.07M PEG- EPS next Q0.03 Inst Own56.24% Short Float10.36% Perf Quarter-15.84%
Sales384.10M P/S3.94 EPS this Y-290.98% Inst Trans1.84% Short Ratio11.29 Perf Half Y7.48%
Book/sh6.06 P/B3.46 EPS next Y228.72% ROA-1.75% Short Interest4.11M Perf Year22.76%
Cash/sh3.10 P/C6.77 EPS next 5Y- ROE-2.15% 52W Range16.56 - 28.15 Perf YTD19.61%
Dividend Est.- P/FCF136.47 EPS past 5Y- ROI-2.04% 52W High-25.47% Beta0.26
Dividend TTM- Quick Ratio2.95 Sales past 5Y98.80% Gross Margin60.88% 52W Low26.69% ATR (14)0.86
Dividend Ex-Date- Current Ratio3.24 EPS Y/Y TTM-30.39% Oper. Margin-6.83% RSI (14)36.39 Volatility2.94% 3.50%
Employees297 Debt/Eq0.02 Sales Y/Y TTM54.41% Profit Margin-2.36% Recom1.00 Target Price36.00
Option/ShortYes / Yes LT Debt/Eq0.02 EPS Q/Q10.33% Payout0.00% Rel Volume0.60 Prev Close21.13
Sales Surprise0.63% EPS Surprise-872.53% Sales Q/Q67.37% EarningsOct 29 BMO Avg Volume364.47K Price20.98
SMA20-3.96% SMA50-11.64% SMA200-4.20% Trades Volume218,075 Change-0.71%
Date Action Analyst Rating Change Price Target Change
Sep-13-24Initiated Jefferies Buy $40
May-03-24Initiated Wells Fargo Overweight $34
Jun-29-20Reiterated BofA Securities Buy $25 → $40
Apr-01-20Initiated BofA/Merrill Buy $25
Mar-11-19Initiated Barclays Overweight $26
Dec-12-18Reiterated Wedbush Outperform $31 → $33
Jun-19-18Initiated JMP Securities Mkt Outperform $33
Nov-26-24 04:01PM
Nov-13-24 10:45AM
Nov-12-24 04:01PM
Oct-30-24 04:25AM
03:07AM
08:45AM Loading…
Oct-29-24 08:45AM
07:30AM
Oct-28-24 09:05AM
08:00AM
Oct-22-24 04:01PM
Oct-09-24 09:55AM
Oct-08-24 09:10PM
Oct-01-24 08:00AM
Aug-28-24 04:01PM
Aug-05-24 09:55AM
12:00PM Loading…
Jul-26-24 12:00PM
08:50AM
Jul-23-24 08:35AM
07:30AM
Jul-16-24 04:01PM
Jul-09-24 08:00AM
08:00AM
Jun-24-24 08:00AM
Jun-17-24 08:30AM
Jun-04-24 04:01PM
Jun-03-24 07:00AM
May-07-24 04:01PM
Apr-24-24 09:00AM
Apr-23-24 11:53AM
08:53AM
08:40AM Loading…
08:40AM
08:36AM
07:30AM
Apr-16-24 04:01PM
Apr-02-24 07:30AM
Mar-01-24 09:55AM
Feb-29-24 11:33PM
12:00PM
09:21AM
Feb-28-24 08:50AM
08:40AM
07:52AM
07:30AM
Feb-21-24 04:01PM
Feb-12-24 09:55AM
08:50AM
Jan-23-24 09:55AM
08:50AM
Jan-09-24 08:46AM
Jan-04-24 07:30AM
Jan-02-24 04:01PM
Dec-23-23 09:00AM
Dec-15-23 02:30PM
Nov-24-23 02:05PM
Nov-20-23 09:55AM
Nov-09-23 10:01PM
Nov-01-23 08:27AM
Oct-31-23 10:48PM
08:50AM
07:30AM
Oct-24-23 04:01PM
Oct-20-23 12:08PM
Sep-29-23 12:43PM
Aug-27-23 08:40AM
Aug-22-23 08:14AM
Aug-18-23 09:04PM
Aug-10-23 10:33PM
Aug-07-23 06:14AM
Jul-25-23 10:05PM
01:06PM
08:45AM
07:30AM
Jul-24-23 08:31AM
Jul-18-23 04:01PM
Jul-17-23 08:00AM
Jul-04-23 08:24PM
Jun-06-23 04:01PM
May-03-23 06:14AM
May-02-23 08:45AM
07:30AM
May-01-23 04:01PM
Apr-09-23 09:21AM
Apr-05-23 01:40PM
Mar-31-23 09:35AM
Mar-30-23 02:20PM
Mar-29-23 10:13AM
Mar-27-23 12:04PM
Mar-23-23 02:25PM
Mar-03-23 06:57PM
Feb-28-23 11:25AM
08:00AM
Feb-27-23 04:01PM
11:47AM
Feb-23-23 10:50AM
Jan-25-23 02:52AM
Jan-21-23 04:51PM
Jan-09-23 08:00AM
Jan-03-23 04:01PM
Nov-30-22 04:01PM
Nov-23-22 04:01PM
Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Ragosa MarkCHIEF FINANCIAL OFFICERDec 03 '24Option Exercise10.768,96996,50631,927Dec 05 07:14 PM
Ragosa MarkCHIEF FINANCIAL OFFICERDec 04 '24Option Exercise10.765,02454,05827,982Dec 05 07:14 PM
Ragosa MarkCHIEF FINANCIAL OFFICERDec 05 '24Option Exercise10.761,12312,08324,081Dec 05 07:14 PM
Ragosa MarkCHIEF FINANCIAL OFFICERDec 03 '24Sale21.458,969192,38522,958Dec 05 07:14 PM
Ragosa MarkCHIEF FINANCIAL OFFICERDec 04 '24Sale21.255,024106,76022,958Dec 05 07:14 PM
Ragosa MarkCHIEF FINANCIAL OFFICERDec 05 '24Sale21.251,12323,86422,958Dec 05 07:14 PM
Ragosa MarkOfficerDec 03 '24Proposed Sale21.2572,7541,546,022Dec 03 05:25 PM
Megna Michael RCHIEF ACCOUNTING OFFICERNov 27 '24Option Exercise11.108,63795,87135,165Dec 02 04:36 PM
Megna Michael RCHIEF ACCOUNTING OFFICERNov 29 '24Option Exercise11.10910026,537Dec 02 04:36 PM
Megna Michael RCHIEF ACCOUNTING OFFICERNov 27 '24Sale22.458,637193,90126,528Dec 02 04:36 PM
Megna Michael RCHIEF ACCOUNTING OFFICERNov 29 '24Sale22.45920226,528Dec 02 04:36 PM
Megna Michael ROfficerNov 27 '24Proposed Sale22.4517,697397,298Nov 27 05:13 PM
Tessari EbenCHIEF OPERATING OFFICERNov 18 '24Option Exercise1.5910,00015,900119,975Nov 20 04:39 PM
Tessari EbenCHIEF OPERATING OFFICERNov 18 '24Sale21.0417,000357,680102,975Nov 20 04:39 PM
Tessari EbenOfficerNov 18 '24Proposed Sale21.0417,000357,641Nov 18 05:50 PM
Patel Sanj KCHAIRMAN & CEONov 06 '24Option Exercise1.5989,561142,402169,112Nov 08 04:34 PM
Patel Sanj KCHAIRMAN & CEONov 06 '24Sale23.0089,5612,059,90379,551Nov 08 04:34 PM
Patel Sanj KOfficerNov 06 '24Proposed Sale23.0089,5612,060,253Nov 06 04:11 PM
Tessari EbenCHIEF OPERATING OFFICEROct 15 '24Option Exercise1.5910,00015,900126,975Oct 17 04:35 PM
Tessari EbenCHIEF OPERATING OFFICEROct 15 '24Sale26.8717,000456,790109,975Oct 17 04:35 PM
Tessari EbenOfficerOct 15 '24Proposed Sale26.8717,000456,789Oct 15 04:57 PM
Tessari EbenCHIEF OPERATING OFFICERSep 23 '24Option Exercise1.5910,00015,900134,475Sep 25 04:39 PM
Tessari EbenCHIEF OPERATING OFFICERSep 23 '24Sale24.9917,500437,325116,975Sep 25 04:39 PM
Tessari EbenOfficerSep 23 '24Proposed Sale24.9917,500437,258Sep 23 05:02 PM
Tessari EbenCHIEF OPERATING OFFICERSep 02 '24Option Exercise0.001,9640125,052Sep 04 08:53 PM
Paolini John F.CHIEF MEDICAL OFFICERSep 03 '24Option Exercise1.8860,692113,809112,730Sep 04 08:52 PM
Paolini John F.CHIEF MEDICAL OFFICERSep 03 '24Sale26.1260,6921,584,99152,038Sep 04 08:52 PM
Moat RossCHIEF COMMERCIAL OFFICERSep 03 '24Option Exercise10.9568,506750,19290,242Sep 04 08:42 PM
Moat RossCHIEF COMMERCIAL OFFICERSep 03 '24Sale26.1268,5061,789,19021,736Sep 04 08:42 PM
Moat RossOfficerSep 03 '24Proposed Sale26.1268,5061,789,288Sep 03 05:17 PM
Paolini John F.OfficerSep 03 '24Proposed Sale26.1290,2172,356,351Sep 03 05:16 PM
Tessari EbenCHIEF OPERATING OFFICERAug 27 '24Option Exercise1.5910,00015,900137,411Aug 29 04:36 PM
Tessari EbenCHIEF OPERATING OFFICERAug 27 '24Sale26.9117,500470,925119,911Aug 29 04:36 PM
Tessari EbenOfficerAug 27 '24Proposed Sale26.9117,500470,904Aug 27 05:17 PM
Patel Sanj KCHAIRMAN & CEOJul 23 '24Option Exercise1.59136,124216,437199,136Jul 25 04:33 PM
Patel Sanj KCHAIRMAN & CEOJul 23 '24Sale25.65136,1243,491,94763,012Jul 25 04:33 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJul 23 '24Option Exercise11.1024,248269,15343,501Jul 25 04:32 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJul 23 '24Sale24.7924,248601,10819,253Jul 25 04:32 PM
Paolini John F.CHIEF MEDICAL OFFICERJul 23 '24Option Exercise1.8622,00040,92069,803Jul 25 04:31 PM
Paolini John F.CHIEF MEDICAL OFFICERJul 23 '24Sale26.3222,000578,96647,803Jul 25 04:31 PM
Patel Sanj KCHAIRMAN & CEOMar 07 '24Sale21.0265,0121,366,5520Mar 11 07:05 PM
Patel Sanj KCHAIRMAN & CEOMar 04 '24Sale21.4912,742273,83470,594Mar 06 05:37 PM
Patel Sanj KCHAIRMAN & CEOMar 06 '24Sale21.005,582117,22265,012Mar 06 05:37 PM
Tessari EbenCHIEF OPERATING OFFICERMar 01 '24Option Exercise1.596561,043124,036Mar 05 04:34 PM
Tessari EbenCHIEF OPERATING OFFICERMar 01 '24Sale22.031,18926,194122,847Mar 05 04:34 PM
Paolini John F.CHIEF MEDICAL OFFICERMar 01 '24Option Exercise1.8618,84435,05062,736Mar 05 04:31 PM
Paolini John F.CHIEF MEDICAL OFFICERMar 01 '24Sale21.7718,844410,23444,892Mar 05 04:31 PM
Megna Michael RCHIEF ACCOUNTING OFFICERMar 01 '24Option Exercise10.939,659105,56027,247Mar 01 06:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERFeb 28 '24Option Exercise8.835,12645,26322,714Mar 01 06:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERMar 01 '24Sale21.459,659207,18617,588Mar 01 06:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERFeb 28 '24Sale21.795,126111,69617,588Mar 01 06:26 PM
Paolini John F.CHIEF MEDICAL OFFICERFeb 27 '24Option Exercise1.8610,15618,89055,048Feb 29 04:26 PM
Paolini John F.CHIEF MEDICAL OFFICERFeb 27 '24Sale21.0310,156213,58144,892Feb 29 04:26 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJan 03 '24Option Exercise8.8312,000105,96027,632Jan 04 04:30 PM
Ragosa MarkCHIEF FINANCIAL OFFICERJan 03 '24Sale20.0012,000240,00015,632Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERJan 02 '24Option Exercise13.8816,670231,38033,675Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERJan 02 '24Sale19.1716,670319,56417,005Jan 04 04:30 PM
Megna Michael RCHIEF ACCOUNTING OFFICERDec 19 '23Option Exercise13.889,316129,30626,321Dec 21 04:26 PM
Megna Michael RCHIEF ACCOUNTING OFFICERDec 19 '23Sale19.139,316178,21517,005Dec 21 04:26 PM
Paolini John F.CHIEF MEDICAL OFFICERDec 07 '23Option Exercise1.8628,60053,19673,492Dec 11 04:20 PM
Paolini John F.CHIEF MEDICAL OFFICERDec 07 '23Sale17.6528,600504,75844,892Dec 11 04:20 PM